Evidence map›Paper›PMID 38496933›Full record

ReviewACS omega2024

How To Get Isocyanate?

Zhuhua Guo, Xiaoshu Ding, Yanji Wang

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhuhua GuoSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300401, PR China.
Xiaoshu DingSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300401, PR China.ORCID https://orcid.org/0000-0002-7902-937X
Yanji WangSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300401, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isocyanate, a pivotal chemical intermediate to synthesize polyurethane with widespread applications in household appliances, automobiles, and construction, is predominantly produced via the phosgene process, which currently holds a paramount status in industrial isocyanate production. Nonetheless, concerns arise from the toxicity of phosgene and the corrosiveness of hydrogen chloride, posing safety hazards. The synthesis of isocyanate using nonphosgene methods represents a promising avenue for future development. This article primarily focuses on the nonphosgene approach, which involves the formation of carbamate through the reaction of nitro-amino compounds with carbon monoxide, dimethyl carbonate, and urea, among other reagents, subsequently leading to the thermal decomposition of carbamate to get isocyanate. This paper emphasizes the progress in catalyst development during the carbamate decomposition process. Single-component metal catalysts, particularly zinc, exhibit advantages such as high activity, cost-effectiveness, and compatibility with a wide range of substrates. Composite catalysts enhance isocyanate yield by introducing a second component to adjust the active metal composition. The central research direction aims to optimize catalyst adaptation to reaction conditions, including temperature, pressure, time, and solvent, to achieve high raw material conversion and product yield.

Identifiers

PMID38496933
PMCPMC10938423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.